Insider · CIK 0001483080
Kostas D Odysseas
Files at AMRN (AMARIN CORP PLC\UK), ARMP (Armata Pharmaceuticals, Inc.). First filing -, latest -.
In brief
Kostas D Odysseas files SEC Form 4 as director at AMRN (AMARIN CORP PLC\UK), and also at ARMP (Armata Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kostas D Odysseas has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 18, 2026 | AMRN AMARIN CORP PLC\UK | MOption exercise American Depositary Shares | +838 | - | - | 1,239 | Apr 21, 2026 |
| Apr 18, 2026 | AMRN AMARIN CORP PLC\UK | FTax withholding American Depositary Shares | -403 | $14.98 | $6,037 | 836 | Apr 21, 2026 |
| Apr 18, 2026 | AMRN AMARIN CORP PLC\UK | MOption exercise Restricted Stock Unitderivative | +838 | $0.00 | $0 | 838 | Apr 21, 2026 |
| Mar 9, 2026 | ARMP Armata Pharmaceuticals, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +25,640 | $0.00 | $0 | 25,640 | Mar 11, 2026 |
| Apr 18, 2025 | AMRN AMARIN CORP PLC\UK | MOption exercise American Depositary Shares | +838 | - | - | 838 | Apr 22, 2025 |
| Apr 18, 2025 | AMRN AMARIN CORP PLC\UK | FTax withholding American Depositary Shares | -437 | $9.11 | $3,981 | 401 | Apr 22, 2025 |
| Apr 18, 2025 | AMRN AMARIN CORP PLC\UK | MOption exercise Restricted Stock Unitderivative | +838 | $0.00 | $0 | 1,676 | Apr 22, 2025 |
| Feb 5, 2025 | ARMP Armata Pharmaceuticals, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +54,343 | $0.00 | $0 | 54,343 | Feb 7, 2025 |
| Mar 14, 2024 | ARMP Armata Pharmaceuticals, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +39,666 | $0.00 | $0 | 39,666 | Mar 18, 2024 |
| Mar 14, 2024 | ARMP Armata Pharmaceuticals, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +54,343 | $0.00 | $0 | 94,009 | Mar 18, 2024 |
| Dec 21, 2023 | ARMP Armata Pharmaceuticals, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +10,461 | $0.00 | $0 | 10,461 | Dec 26, 2023 |
Questions about Kostas D Odysseas
Answered from the filings on this page, as of the latest one.
Is Kostas D Odysseas buying or selling?
Kostas D Odysseas has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kostas D Odysseas's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kostas D Odysseas has 0.
Where does Kostas D Odysseas file Form 4?
Kostas D Odysseas has filed Form 4 at AMRN (AMARIN CORP PLC\UK); ARMP (Armata Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.